HEADER VIRAL PROTEIN/DNA 27-MAY-22 7XWZ TITLE CRYSTAL STRUCTURE OF SARS-COV-2 N-NTD AND DSRNA COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN; COMPND 5 SYNONYM: N,NUCLEOCAPSID PROTEIN,NC,PROTEIN N; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: RNA (5'-R(*CP*AP*CP*UP*GP*AP*C)-3'); COMPND 9 CHAIN: C, E; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: RNA (5'-R(P*GP*UP*CP*AP*GP*UP*G)-3'); COMPND 13 CHAIN: D, F; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630 KEYWDS STRUCTURAL PROTEIN, DRUG TARGET, VIRAL PROTEIN, VIRAL PROTEIN-DNA KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.D.LUAN,X.M.LI,Y.F.LI REVDAT 2 29-NOV-23 7XWZ 1 REMARK REVDAT 1 08-FEB-23 7XWZ 0 JRNL AUTH X.LUAN,X.LI,Y.LI,G.SU,W.YIN,Y.JIANG,N.XU,F.WANG,W.CHENG, JRNL AUTH 2 Y.JIN,L.ZHANG,H.E.XU,Y.XUE,S.ZHANG JRNL TITL ANTIVIRAL DRUG DESIGN BASED ON STRUCTURAL INSIGHTS INTO THE JRNL TITL 2 N-TERMINAL DOMAIN AND C-TERMINAL DOMAIN OF THE SARS-COV-2 JRNL TITL 3 NUCLEOCAPSID PROTEIN. JRNL REF SCI BULL (BEIJING) V. 67 2327 2022 JRNL REFN ISSN 2095-9273 JRNL PMID 36317101 JRNL DOI 10.1016/J.SCIB.2022.10.021 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 16773 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.853 REMARK 3 FREE R VALUE TEST SET COUNT : 814 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1178 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.44 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 61 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1815 REMARK 3 NUCLEIC ACID ATOMS : 590 REMARK 3 HETEROGEN ATOMS : 18 REMARK 3 SOLVENT ATOMS : 86 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.88400 REMARK 3 B22 (A**2) : -2.33700 REMARK 3 B33 (A**2) : 3.22200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.43400 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.340 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.244 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.816 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2587 ; 0.003 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 2028 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3593 ; 1.287 ; 1.697 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4695 ; 1.010 ; 1.596 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 367 ; 6.632 ; 7.016 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 101 ;28.569 ;21.782 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 274 ;12.965 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;17.179 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 394 ; 0.140 ; 0.212 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2514 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 570 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 406 ; 0.159 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 47 ; 0.206 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1105 ; 0.184 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 82 ; 0.127 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 935 ; 1.665 ; 4.146 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 934 ; 1.665 ; 4.144 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1164 ; 2.832 ; 6.196 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1165 ; 2.831 ; 6.197 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1652 ; 1.731 ; 5.302 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1653 ; 1.731 ; 5.302 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2428 ; 2.833 ; 7.887 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2429 ; 2.833 ; 7.887 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7XWZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1300029835. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.18057 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16782 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 47.977 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2OFZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MALONIC ACID, IMIDAZOLE, BORIC ACID, REMARK 280 PEG 1500, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.55950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -96.55842 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 19.55950 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -83.41675 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 91 REMARK 465 ARG A 92 REMARK 465 ARG A 93 REMARK 465 ILE A 94 REMARK 465 ARG A 95 REMARK 465 GLY A 96 REMARK 465 GLY A 97 REMARK 465 ASP A 98 REMARK 465 GLY A 99 REMARK 465 LYS A 100 REMARK 465 MET A 101 REMARK 465 LYS A 102 REMARK 465 TYR A 172 REMARK 465 ASP B 98 REMARK 465 GLY B 99 REMARK 465 LYS B 100 REMARK 465 MET B 101 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 U F 2 C3' - O3' - P ANGL. DEV. = -7.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL DBREF 7XWZ A 48 172 UNP P0DTC9 NCAP_SARS2 48 172 DBREF 7XWZ B 48 172 UNP P0DTC9 NCAP_SARS2 48 172 DBREF 7XWZ C 1 7 PDB 7XWZ 7XWZ 1 7 DBREF 7XWZ D 1 7 PDB 7XWZ 7XWZ 1 7 DBREF 7XWZ E 1 7 PDB 7XWZ 7XWZ 1 7 DBREF 7XWZ F 1 7 PDB 7XWZ 7XWZ 1 7 SEQRES 1 A 125 ASN THR ALA SER TRP PHE THR ALA LEU THR GLN HIS GLY SEQRES 2 A 125 LYS GLU ASP LEU LYS PHE PRO ARG GLY GLN GLY VAL PRO SEQRES 3 A 125 ILE ASN THR ASN SER SER PRO ASP ASP GLN ILE GLY TYR SEQRES 4 A 125 TYR ARG ARG ALA THR ARG ARG ILE ARG GLY GLY ASP GLY SEQRES 5 A 125 LYS MET LYS ASP LEU SER PRO ARG TRP TYR PHE TYR TYR SEQRES 6 A 125 LEU GLY THR GLY PRO GLU ALA GLY LEU PRO TYR GLY ALA SEQRES 7 A 125 ASN LYS ASP GLY ILE ILE TRP VAL ALA THR GLU GLY ALA SEQRES 8 A 125 LEU ASN THR PRO LYS ASP HIS ILE GLY THR ARG ASN PRO SEQRES 9 A 125 ALA ASN ASN ALA ALA ILE VAL LEU GLN LEU PRO GLN GLY SEQRES 10 A 125 THR THR LEU PRO LYS GLY PHE TYR SEQRES 1 B 125 ASN THR ALA SER TRP PHE THR ALA LEU THR GLN HIS GLY SEQRES 2 B 125 LYS GLU ASP LEU LYS PHE PRO ARG GLY GLN GLY VAL PRO SEQRES 3 B 125 ILE ASN THR ASN SER SER PRO ASP ASP GLN ILE GLY TYR SEQRES 4 B 125 TYR ARG ARG ALA THR ARG ARG ILE ARG GLY GLY ASP GLY SEQRES 5 B 125 LYS MET LYS ASP LEU SER PRO ARG TRP TYR PHE TYR TYR SEQRES 6 B 125 LEU GLY THR GLY PRO GLU ALA GLY LEU PRO TYR GLY ALA SEQRES 7 B 125 ASN LYS ASP GLY ILE ILE TRP VAL ALA THR GLU GLY ALA SEQRES 8 B 125 LEU ASN THR PRO LYS ASP HIS ILE GLY THR ARG ASN PRO SEQRES 9 B 125 ALA ASN ASN ALA ALA ILE VAL LEU GLN LEU PRO GLN GLY SEQRES 10 B 125 THR THR LEU PRO LYS GLY PHE TYR SEQRES 1 C 7 C A C U G A C SEQRES 1 D 7 G U C A G U G SEQRES 1 E 7 C A C U G A C SEQRES 1 F 7 G U C A G U G HET EDO A 201 4 HET EDO B 201 4 HET GOL B 202 6 HET EDO C 101 4 HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 7 EDO 3(C2 H6 O2) FORMUL 9 GOL C3 H8 O3 FORMUL 11 HOH *86(H2 O) HELIX 1 AA1 SER A 79 ASP A 82 5 4 HELIX 2 AA2 SER B 79 ASP B 82 5 4 SHEET 1 AA1 4 LEU A 56 THR A 57 0 SHEET 2 AA1 4 ARG A 107 TYR A 112 -1 O TRP A 108 N LEU A 56 SHEET 3 AA1 4 ILE A 84 ARG A 89 -1 N TYR A 86 O TYR A 111 SHEET 4 AA1 4 ILE A 130 ALA A 134 -1 O ILE A 131 N TYR A 87 SHEET 1 AA2 4 LEU B 56 THR B 57 0 SHEET 2 AA2 4 ARG B 107 TYR B 112 -1 O TRP B 108 N LEU B 56 SHEET 3 AA2 4 ILE B 84 ALA B 90 -1 N ARG B 88 O TYR B 109 SHEET 4 AA2 4 ILE B 130 ALA B 134 -1 O VAL B 133 N GLY B 85 CRYST1 53.848 39.119 84.157 90.00 97.61 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018571 0.000000 0.002480 0.00000 SCALE2 0.000000 0.025563 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011988 0.00000